United States Recombinant Human Endostatin Market Report 2016

United States Recombinant Human Endostatin Market Report 2016

1 Recombinant Human Endostatin Overview

1.1 Product Overview and Scope of Recombinant Human Endostatin

1.2 Classification of Recombinant Human Endostatin

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Recombinant Human Endostatin

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Recombinant Human Endostatin (2011-2021)

1.4.1 USA Recombinant Human Endostatin Sales and Growth Rate (2011-2021)

1.4.2 USA Recombinant Human Endostatin Revenue and Growth Rate (2011-2021)

2 USA Recombinant Human Endostatin Competition by Manufacturers

2.1 USA Recombinant Human Endostatin Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Recombinant Human Endostatin Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Recombinant Human Endostatin Average Price by Manufactures (2015 and 2016)

2.4 Recombinant Human Endostatin Market Competitive Situation and Trends

2.4.1 Recombinant Human Endostatin Market Concentration Rate

2.4.2 Recombinant Human Endostatin Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Recombinant Human Endostatin Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Recombinant Human Endostatin Sales and Market Share by Type (2011-2016)

3.2 USA Recombinant Human Endostatin Revenue and Market Share by Type (2011-2016)

3.3 USA Recombinant Human Endostatin Price by Type (2011-2016)

3.4 USA Recombinant Human Endostatin Sales Growth Rate by Type (2011-2016)

4 USA Recombinant Human Endostatin Sales (Volume) by Application (2011-2016)

4.1 USA Recombinant Human Endostatin Sales and Market Share by Application (2011-2016)

4.2 USA Recombinant Human Endostatin Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Recombinant Human Endostatin Manufacturers Profiles/Analysis

5.1 Pfizer

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Recombinant Human Endostatin Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Pfizer Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Allergan

5.2.2 Recombinant Human Endostatin Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Allergan Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Alnylam Pharmaceuticals

5.3.2 Recombinant Human Endostatin Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Alnylam Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Amgen

5.4.2 Recombinant Human Endostatin Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Amgen Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Angstrom Pharmaceuticals

5.5.2 Recombinant Human Endostatin Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Angstrom Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Acceleron Pharma

5.6.2 Recombinant Human Endostatin Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Acceleron Pharma Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Biocon

5.7.2 Recombinant Human Endostatin Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Biocon Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Bionomics

5.8.2 Recombinant Human Endostatin Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Bionomics Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 CASI Pharmaceuticals

5.9.2 Recombinant Human Endostatin Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 CASI Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Celgene Corporation

5.10.2 Recombinant Human Endostatin Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Celgene Corporation Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Enzon Pharmaceuticals

5.12 Five Prime Therapeutics

5.13 Fujifilm Kyowa Kirin Biologics

5.14 Genentech

5.15 Genexine

5.16 Hetero Drugs

5.17 ImClone Systems

5.18 Intas Pharmaceuticals

5.19 Kyowa Hakko Kirin

5.20 Levolta Pharmaceuticals

5.21 Mabtech

5.22 Marsala Biotech

5.23 Neumedicines

5.24 Novartis

5.25 Oncobiologics

5.26 Onyx Pharmaceuticals

6 Recombinant Human Endostatin Manufacturing Cost Analysis

6.1 Recombinant Human Endostatin Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Recombinant Human Endostatin

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Recombinant Human Endostatin Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Recombinant Human Endostatin Market Forecast (2016-2021)

10.1 USA Recombinant Human Endostatin Sales, Revenue Forecast (2016-2021)

10.2 USA Recombinant Human Endostatin Sales Forecast by Type (2016-2021)

10.3 USA Recombinant Human Endostatin Sales Forecast by Application (2016-2021)

10.4 Recombinant Human Endostatin Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Recombinant Human Endostatin

Table Classification of Recombinant Human Endostatin

Figure USA Sales Market Share of Recombinant Human Endostatin by Type in 2015

Table Application of Recombinant Human Endostatin

Figure USA Sales Market Share of Recombinant Human Endostatin by Application in 2015

Figure USA Recombinant Human Endostatin Sales and Growth Rate (2011-2021)

Figure USA Recombinant Human Endostatin Revenue and Growth Rate (2011-2021)

Table USA Recombinant Human Endostatin Sales of Key Manufacturers (2015 and 2016)

Table USA Recombinant Human Endostatin Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Recombinant Human Endostatin Sales Share by Manufacturers

Figure 2016 Recombinant Human Endostatin Sales Share by Manufacturers

Table USA Recombinant Human Endostatin Revenue by Manufacturers (2015 and 2016)

Table USA Recombinant Human Endostatin Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Recombinant Human Endostatin Revenue Share by Manufacturers

Table 2016 USA Recombinant Human Endostatin Revenue Share by Manufacturers

Table USA Market Recombinant Human Endostatin Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Recombinant Human Endostatin Average Price of Key Manufacturers in 2015

Figure Recombinant Human Endostatin Market Share of Top 3 Manufacturers

Figure Recombinant Human Endostatin Market Share of Top 5 Manufacturers

Table USA Recombinant Human Endostatin Sales by Type (2011-2016)

Table USA Recombinant Human Endostatin Sales Share by Type (2011-2016)

Figure USA Recombinant Human Endostatin Sales Market Share by Type in 2015

Table USA Recombinant Human Endostatin Revenue and Market Share by Type (2011-2016)

Table USA Recombinant Human Endostatin Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Recombinant Human Endostatin by Type (2011-2016)

Table USA Recombinant Human Endostatin Price by Type (2011-2016)

Figure USA Recombinant Human Endostatin Sales Growth Rate by Type (2011-2016)

Table USA Recombinant Human Endostatin Sales by Application (2011-2016)

Table USA Recombinant Human Endostatin Sales Market Share by Application (2011-2016)

Figure USA Recombinant Human Endostatin Sales Market Share by Application in 2015

Table USA Recombinant Human Endostatin Sales Growth Rate by Application (2011-2016)

Figure USA Recombinant Human Endostatin Sales Growth Rate by Application (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Allergan Basic Information List

Table Allergan Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Allergan Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Alnylam Pharmaceuticals Basic Information List

Table Alnylam Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Alnylam Pharmaceuticals Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amgen Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Angstrom Pharmaceuticals Basic Information List

Table Angstrom Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Angstrom Pharmaceuticals Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Acceleron Pharma Basic Information List

Table Acceleron Pharma Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Acceleron Pharma Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Biocon Basic Information List

Table Biocon Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Biocon Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Bionomics Basic Information List

Table Bionomics Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bionomics Recombinant Human Endostatin Sales Market Share (2011-2016)

Table CASI Pharmaceuticals Basic Information List

Table CASI Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table CASI Pharmaceuticals Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Celgene Corporation Basic Information List

Table Celgene Corporation Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Celgene Corporation Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Enzon Pharmaceuticals Basic Information List

Table Enzon Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Enzon Pharmaceuticals Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Five Prime Therapeutics Basic Information List

Table Five Prime Therapeutics Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Five Prime Therapeutics Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Fujifilm Kyowa Kirin Biologics Basic Information List

Table Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Genentech Basic Information List

Table Genentech Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genentech Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Genexine Basic Information List

Table Genexine Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genexine Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Hetero Drugs Basic Information List

Table Hetero Drugs Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Hetero Drugs Recombinant Human Endostatin Sales Market Share (2011-2016)

Table ImClone Systems Basic Information List

Table ImClone Systems Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table ImClone Systems Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Intas Pharmaceuticals Basic Information List

Table Intas Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Intas Pharmaceuticals Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Kyowa Hakko Kirin Basic Information List

Table Kyowa Hakko Kirin Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Kyowa Hakko Kirin Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Levolta Pharmaceuticals Basic Information List

Table Levolta Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Levolta Pharmaceuticals Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Mabtech Basic Information List

Table Mabtech Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mabtech Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Marsala Biotech Basic Information List

Table Marsala Biotech Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Marsala Biotech Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Neumedicines Basic Information List

Table Neumedicines Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Neumedicines Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Oncobiologics Basic Information List

Table Oncobiologics Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Oncobiologics Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Onyx Pharmaceuticals Basic Information List

Table Onyx Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Onyx Pharmaceuticals Recombinant Human Endostatin Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Recombinant Human Endostatin

Figure Manufacturing Process Analysis of Recombinant Human Endostatin

Figure Recombinant Human Endostatin Industrial Chain Analysis

Table Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015

Table Major Buyers of Recombinant Human Endostatin

Table Distributors/Traders List

Figure USA Recombinant Human Endostatin Production and Growth Rate Forecast (2016-2021)

Figure USA Recombinant Human Endostatin Revenue and Growth Rate Forecast (2016-2021)

Table USA Recombinant Human Endostatin Production Forecast by Type (2016-2021)

Table USA Recombinant Human Endostatin Consumption Forecast by Application (2016-2021)